Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Meyer

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2014
Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primatesKathrin Meyer, Laura Ferraiuolo, Leah Schmelzer, et al.
Annals of Clinical and Translational Neurology|February 11, 2014
Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of ConceptW David Arnold, Paul N Porensky, Vicki L McGovern, et al.
Glia|October 10, 2022
CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosisCassandra N Dennys, Florence Roussel, Rochelle Rodrigo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codesMark E Hester, Matthew J Murtha, SungWon Song, et al.
Thyroid : Official Journal of the American Thyroid Association|March 30, 2022
AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-DeficiencyXiao-Hui Liao, Pablo Avalos, Oksana Shelest, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Human Molecular Genetics|April 13, 2018
Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neuronsVeronika Boczonadi, Kathrin Meyer, Humberto Gonczarowska-Jorge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2016
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanismLaura Ferraiuolo, Kathrin Meyer, Thomas W Sherwood, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2014
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALSKathrin Meyer, Laura Ferraiuolo, Carlos J Miranda, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2021
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease miceKatherine A White, Hemanth R Nelvagal, Timothy A Poole, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2014
Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primatesKathrin Meyer, Laura Ferraiuolo, Leah Schmelzer, et al.
Annals of Clinical and Translational Neurology|February 11, 2014
Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of ConceptW David Arnold, Paul N Porensky, Vicki L McGovern, et al.
Glia|October 10, 2022
CuATSM effectively ameliorates ALS patient astrocyte-mediated motor neuron toxicity in human in vitro models of amyotrophic lateral sclerosisCassandra N Dennys, Florence Roussel, Rochelle Rodrigo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codesMark E Hester, Matthew J Murtha, SungWon Song, et al.
Thyroid : Official Journal of the American Thyroid Association|March 30, 2022
AAV9-MCT8 Delivery at Juvenile Stage Ameliorates Neurological and Behavioral Deficits in a Mouse Model of MCT8-DeficiencyXiao-Hui Liao, Pablo Avalos, Oksana Shelest, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2020
AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten DiseaseTyler B Johnson, Katherine A White, Jon J Brudvig, et al.
Human Molecular Genetics|April 13, 2018
Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neuronsVeronika Boczonadi, Kathrin Meyer, Humberto Gonczarowska-Jorge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2016
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanismLaura Ferraiuolo, Kathrin Meyer, Thomas W Sherwood, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2014
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALSKathrin Meyer, Laura Ferraiuolo, Carlos J Miranda, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2021
Intracranial delivery of AAV9 gene therapy partially prevents retinal degeneration and visual deficits in CLN6-Batten disease miceKatherine A White, Hemanth R Nelvagal, Timothy A Poole, et al.
Pageof 7